Stock News - ARVINAS, INC. $ARVN

Latest Stock News for $ARVN
Arvinas, Inc. Reports Positive Phase 1 Data for ARV-102 in Parkinson's Disease

Expected Stock impact: Very Positive
2026-03-18 11:10:00